Stockscreener 앱 받기
4.95
13.01%
-0.74
전일 마감가:
$5.69
열려 있는:
$5.6
하루 거래량:
701.70K
Relative Volume:
2.58
시가총액:
$129.74M
수익:
$47.26M
순이익/손실:
$-58.48M
주가수익비율:
-1.83
EPS:
-2.7049
순현금흐름:
$-40.45M
1주 성능:
-24.43%
1개월 성능:
-18.99%
6개월 성능:
-35.88%
1년 성능:
-65.84%
1일 변동 폭
$4.715
$5.67
1주일 범위
$4.715
$7.03
52주 변동 폭
$4.2993
$15.41
Cvrx Inc Stock (CVRX) Company Profile
명칭
Cvrx Inc
전화
(763) 416-2850
주소
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Compare CVRX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
4.95 | 149.14M | 47.26M | -58.48M | -40.45M | -2.7049 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-09 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-01-14 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-09-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-07-11 | 재확인 | Lake Street | Buy |
| 2024-05-01 | 재개 | Craig Hallum | Buy |
| 2024-05-01 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-05-01 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | 개시 | Lake Street | Buy |
| 2022-07-18 | 개시 | Craig Hallum | Buy |
| 2021-07-26 | 개시 | Canaccord Genuity | Buy |
| 2021-07-26 | 개시 | Piper Sandler | Overweight |
| 2021-07-26 | 개시 | William Blair | Outperform |
모두보기
Cvrx Inc 주식(CVRX)의 최신 뉴스
Canaccord Genuity lowers CVRx stock price target to $10 on sector multiple decline - Investing.com Nigeria
CVRx Earnings Call: Investing Heavily for Future Growth - TipRanks
Canaccord Genuity lowers CVRx stock price target to $10 on sector multiple decline By Investing.com - Investing.com India
CVRx, Inc. SEC 10-K Report - TradingView
CVRx revenue up 4% to USD 16M in Q4 2025 - Medical Buyer
CVRx Q4 2025 Earnings Call Transcript - MarketBeat
Responsive Playbooks and the CVRX Inflection - Stock Traders Daily
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc.CVRX - PR Newswire
CVRx Q4 Earnings Call Highlights - MarketBeat
CVRX: Revenue and margin growth set the stage for accelerated expansion with new reimbursement and clinical trial catalysts - TradingView
CVRx earnings missed by $0.02, revenue topped estimates - Investing.com Canada
CVRx (CVRX) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: CVRx Q4 2025 sees stock surge despite earnings miss - Investing.com
CVRx Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - Bitget
CVRx (NASDAQ:CVRX) Announces Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat
CVRx: Q4 Earnings Snapshot - kare11.com
CVRx: Fourth Quarter Financial Highlights - Bitget
CVRx (CVRX) Q4 2025 Earnings Call Transcript - The Globe and Mail
What’s the beta of CVRx Inc. stockOil Prices & Weekly Setup with High ROI Potential - mfd.ru
Will CVRX benefit from government policyJuly 2025 News Drivers & Fast Moving Stock Watchlists - mfd.ru
CVRx's Earnings: A Preview - Benzinga
Can CVRx Inc. expand into new markets2025 Growth vs Value & AI Driven Stock Reports - mfd.ru
CVRX INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving CVRx Inc. - Business Wire
Does CVRx Inc. meet Warren Buffett’s criteria2025 Valuation Update & Long Hold Capital Preservation Plans - mfd.ru
CVRx, Inc. (NASDAQ:CVRX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Growth Value: Should you buy the dip on CVRx IncJuly 2025 Retail & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Returns Recap: Whats the beta of CVRx Inc stockJuly 2025 Review & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
CVRx showcases Barostim integration at heart failure program - Traders Union
S P Trends: Whats the beta of CVRx Inc stockJuly 2025 Retail & Daily Profit Maximizing Tips - baoquankhu1.vn
Income Plays: How correlated is CVRX to the S P5002025 Trading Recap & Verified Entry Point Signals - baoquankhu1.vn
Understanding the Setup: (CVRX) and Scalable Risk - Stock Traders Daily
CVRx ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
CVRx ALERT: Bragar Eagel & Squire, P.C. is Investigating CVRx Inc. on Behalf of CVRx Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
CVRx to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call on February 12, 2026 - Sahm
CVRx INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud - Business Wire
Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc.CVRX - marketscreener.com
Setup Watch: Will CVRX stock recover faster than peersWeekly Trend Recap & Weekly High Potential Stock Alerts - mfd.ru
Swing Trade: Will CVRx Inc announce a stock splitMarket Trend Report & AI Optimized Trade Strategies - baoquankhu1.vn
CVRx: Barostim gains new CPT codes for 2026 - Traders Union
Gains Recap: Whats the fair value of CVRX stockMarket Activity Summary & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
CVRx (CVRX) to Release Earnings on Tuesday - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of CVRx, Inc. – CVRX - ChartMill
CVRx supports MU Health with first Barostim implant - Traders Union
The Truth About CVRx Inc: Wall Street’s Sleeping Giant You’re Not Watching (Yet) - AD HOC NEWS
CVRx Kicks Off One Of The Largest Heart Device Trials In History - Sahm
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Maravai Lifesciences Holdings (MRVI) and CVRx (CVRX) - The Globe and Mail
Downgrade Watch: Should value investors consider CVRXWeekly Risk Report & Smart Swing Trading Alerts - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: CVRx (CVRX) and EyePoint Pharmaceuticals (EYPT) - The Globe and Mail
Craig-Hallum Maintains CVRx Inc(CVRX.US) With Buy Rating - 富途资讯
CVRx’s stock up as heart failure device to be trialled in expanded patient group - Yahoo Finance
CVRx launches major heart failure trial to expand Barostim therapy reach - Investing.com Australia
Cvrx Inc (CVRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Cvrx Inc 주식 (CVRX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| JOHNSON & JOHNSON | 10% Owner |
Nov 24 '25 |
Sale |
10.06 |
2,200 |
22,132 |
4,047,198 |
| JOHNSON & JOHNSON | 10% Owner |
Nov 21 '25 |
Sale |
10.00 |
500 |
5,000 |
4,049,398 |
| JOHNSON & JOHNSON | 10% Owner |
Nov 12 '25 |
Sale |
10.00 |
1,000 |
10,000 |
4,049,898 |
| JOHNSON & JOHNSON | 10% Owner |
Nov 06 '25 |
Sale |
10.21 |
52,332 |
534,310 |
4,051,098 |
| JOHNSON & JOHNSON | 10% Owner |
Nov 07 '25 |
Sale |
10.00 |
200 |
2,000 |
4,050,898 |
| Nielsen Kirk G. | Director |
May 15 '25 |
Buy |
5.45 |
10,966 |
59,795 |
1,910,134 |
| Nielsen Kirk G. | Director |
May 13 '25 |
Buy |
5.29 |
101,413 |
536,313 |
1,837,968 |
| Nielsen Kirk G. | Director |
May 14 '25 |
Buy |
5.23 |
61,200 |
320,364 |
1,899,168 |
| Nielsen Kirk G. | Director |
May 12 '25 |
Buy |
4.79 |
25,200 |
120,670 |
1,736,555 |
| Jain Mudit K. | Director |
May 12 '25 |
Buy |
4.66 |
1,500 |
6,986 |
4,900 |
1.33%
0.51%
자본화:
|
볼륨(24시간):